United States · FDA National Drug Code directory
Horizant
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 53451-0101_33da187f-72d1-daa5-e063-6394a90a66b1
- Product NDC
- 53451-0101
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- gabapentin enacarbil
- Labeler
- Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
- Marketing category
- NDA
- Marketing start / end (source format)
- 20130501
- Source listing expiry
- 20261231
Source-listed ingredients
- GABAPENTIN ENACARBIL — 600 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (53451-0101-1) · 53451-0101-1
- 5 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (53451-0101-9) · 53451-0101-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →